EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Increasing Adenovirus Upstream Process Productivity Using a High Cell Density Perfusion Strategy

Alena Roßkamp, Jacqueline Vieira, Shawkat Hussain, Julia Talarek iD, Faith Vinluan iD, Carina C D Joe, Steffi Scholze, Moritz Speckenbach, Paul Madarasi-Pap, Sophia Kueppers, Julia Niemann, Alexander D Douglas iD

Biotechnology and Bioengineering · 2026-11-18

DOI: 10.1002/bit.70443 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2026-11-18. Written by Alena Roßkamp and 11 co-authors. Institution: Sartorius Stedim Biotech GmbH, Goettingen, Germany. 38 references. The full text is freely available (open access, CC BY 4.0). Funded by: Sartorius Stedim Biotech GmbH, Engineering and Physical Sciences Research Council Manufacturing Research Hub for a Sustainable Future (VaxHub Sustainable), UK Department of Health and Social Care VaxHub Global project.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Adenovirus vectors are a major vaccine platform and have potential roles as oncolytics and gene therapies. Large‐scale production of adenovirus‐vectored COVID‐19 vaccines demonstrated the value of platform manufacturing processes for such products but vaccine scarcity remained problematic in 2021. There is a need for widely‐accessible and higher‐yielding platform processes for adenovirus production. Such processes must overcome cell‐density‐associated productivity limitation and the potential impact of vector transgene expression. We report a process capable of upstream productivity of 3 ×10 12 virus particles per mL, solely using commercially‐accessible materials. This combines perfusion cell culture with a highly‐productive cell line capable of vector transgene repression. Using a multi‐parallel scaledown perfusion bioreactor system, we selected straightforward perfusion conditions for both expansion of uninfected cells and virus production. This achieves maintenance of high cell‐specific productivity at cell densities up to 40 ×10 6 cells per mL. We believe this may be the highest productivity yet reported for an adenovirus platform, including previous reports using proprietary cell lines. This highly productive process could be valuable both in large‐scale production and in maximizing the output of smaller facilities making products for niche indications or stockpiles.

Subjects

Author keywords

Ambr250 HT bioreactorChAdOx vectorExpi293 cell lineadenovirusperfusion culturevaccine manufacturing

Authors and institutions

  • Sartorius Stedim Biotech GmbH, Goettingen, Germany.
  • Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

ORCID profiles: Julia Talarek, Faith Vinluan, Alexander D Douglas

Funding

  • Sartorius Stedim Biotech GmbH
  • Engineering and Physical Sciences Research Council Manufacturing Research Hub for a Sustainable Future (VaxHub Sustainable)
  • UK Department of Health and Social Care VaxHub Global project
  • Wellcome

Cite

APA

Roßkamp, A., Vieira, J., Hussain, S., Talarek, J., Vinluan, F., Joe, C. C. D., Scholze, S., Speckenbach, M., Madarasi-Pap, P., Kueppers, S., Niemann, J., & Douglas, A. D. (2026). Increasing Adenovirus Upstream Process Productivity Using a High Cell Density Perfusion Strategy. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70443

Vancouver

Roßkamp A, Vieira J, Hussain S, Talarek J, Vinluan F, Joe CCD, et al. Increasing Adenovirus Upstream Process Productivity Using a High Cell Density Perfusion Strategy. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70443

BibTeX
@article{Rokamp2026,
  author = {Roßkamp, Alena and Vieira, Jacqueline and Hussain, Shawkat and Talarek, Julia and Vinluan, Faith and Joe, Carina C D and Scholze, Steffi and Speckenbach, Moritz and Madarasi-Pap, Paul and Kueppers, Sophia and Niemann, Julia and Douglas, Alexander D},
  title = {Increasing Adenovirus Upstream Process Productivity Using a High Cell Density Perfusion Strategy},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70443}
}
Start for free →